Related Experiment Video
Updated: May 12, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Azole resistance in Aspergillus fumigatus- comprehensive review
Mthokozisi Dladla1, Marieka Gyzenhout2, Gert Marias3
1Department of Genetics, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, 9301, South Africa.
Abstract:
Aspergillus fumigatus is a ubiquitous filamentous fungus commonly found in the environment. It is also an opportunistic human pathogen known to cause a range of respiratory infections, such as invasive aspergillosis, particularly in immunocompromised individuals. Azole antifungal agents are widely used for the treatment and prophylaxis of Aspergillus infections due to their efficacy and tolerability. However, the emergence of azole resistance in A. fumigatus has become a major concern in recent years due to their association with increased treatment failures and mortality rates. The development of azole resistance in A. fumigatus can occur through both acquired and intrinsic mechanisms. Acquired resistance typically arises from mutations in the target enzyme, lanosterol 14-α-demethylase (Cyp51A), reduces the affinity of azole antifungal agents for the enzyme, rendering them less effective, while intrinsic resistance refers to a natural resistance of certain A. fumigatus isolates to azole antifungals due to inherent genetic characteristics. The current review aims to provide a comprehensive overview of azole antifungal resistance in A. fumigatus, discusses underlying resistance mechanisms, including alterations in the target enzyme, Cyp51A, and the involvement of efflux pumps in drug efflux. Impact of azole fungicide uses in the environment and the spread of resistant strains is also explored.
Insights
Azole resistance in Aspergillus fumigatus is a growing concern, leading to treatment failures. Understanding resistance mechanisms, like Cyp51A mutations and efflux pumps, is crucial for combating fungal infections.
Area of Science:
- Mycology
- Antimicrobial Resistance
- Medical Mycology
Background:
- Aspergillus fumigatus is a common fungus causing respiratory infections, especially in immunocompromised individuals.
- Azole antifungals are standard treatments, but resistance is emerging.
- Azole resistance in A. fumigatus is linked to higher treatment failure and mortality.
Purpose of the Study:
- To provide a comprehensive review of azole antifungal resistance in A. fumigatus.
- To discuss the mechanisms of azole resistance.
- To explore the impact of environmental fungicide use on resistant strain spread.
Main Methods:
- Literature review of studies on azole resistance in A. fumigatus.
- Analysis of genetic and molecular mechanisms of resistance.
- Examination of epidemiological data and environmental factors.
Main Results:
- Azole resistance in A. fumigatus is mediated by acquired (e.g., Cyp51A mutations) and intrinsic mechanisms.
- Mutations in lanosterol 14-α-demethylase (Cyp51A) reduce azole drug affinity.
- Efflux pumps contribute to drug resistance by expelling antifungals.
- Environmental azole fungicide use may drive the selection and spread of resistant strains.
Conclusions:
- Azole resistance in A. fumigatus poses a significant threat to public health.
- Understanding resistance mechanisms is key to developing effective treatment and control strategies.
- Addressing environmental fungicide use is important to mitigate the spread of resistant strains.
Related Concept Videos
Overview of Fungi
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Antifungal Agents

